Unusual DNA conformations: implications for telomeres

Curr Med Chem Anticancer Agents. 2002 Sep;2(5):627-44. doi: 10.2174/1568011023353877.

Abstract

DNA is prone to structural polymorphism: its three-dimensional structure can differ markedly from the classical double helix. Nucleic acid structures composed of more than two strands have also been observed. The guanine-rich sequence of both the telomere and centromere can form a quadruplex based on G-quartets while the complementary cytosine-rich strand can fold into an intercalated tetramer called the i-motif. The G-quartet is a gold mine for structural biologists and the telomere has become a target for anti-cancer drug design since it was observed that deregulation of telomerase favors proliferation of certain tumors. Other DNA sequences may adopt unusual conformations. Polypurine-polypyrimidine sequences capable of forming a triple-stranded structure called H-DNA are found abundantly in the eukaryotic genome and may play a significant role in DNA metabolism, transcription and replication. Triplex-forming oligonucleotides are currently being developed as "anti-gene" agents. Unusual DNA structures may therefore be implicated in fundamental processes such as gene expression and represent unique targets for both structural-specific and sequence-specific agents. In this review, we present work characterizing some of these unusual conformations in terms of structure, stability and formation kinetics and discuss their biological implications.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • DNA / chemistry*
  • DNA / therapeutic use
  • Gene Expression Regulation, Neoplastic / drug effects
  • Humans
  • Nucleic Acid Conformation
  • Oligonucleotides / chemistry
  • Oligonucleotides / pharmacology
  • Oligonucleotides / therapeutic use*
  • Telomere / drug effects*

Substances

  • Antineoplastic Agents
  • Oligonucleotides
  • DNA